Jump to content
Sclero Forums
Jeannie McClelland

Diagnostic value of anti-topoisomerase I antibodies

Recommended Posts

Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort. Diagnosis and risk assessment of scleroderma patients can be supported by the detection of anti-topo I antibodies. Signal intensities as obtained by LIA or ELISA can be used as a surrogate marker for fibrosis, active disease and worse prognosis. K. Hanke. Arthritis Research & Therapy 2009, 11:R28. (Also see: What are Antibodies?)


This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.

Jeannie McClelland

(Retired) ISN Director of Support Services

(Retired) ISN Sclero Forums Manager

(Retired) ISN Blog Manager

(Retired) ISN Assistant News Guide

(Retired) ISN Artist

International Scleroderma Network

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now